Geisinger & Tempus Create AI Model to Identify Structural Heart Disease - - HIT Consultant

Tempus launches a collaborative study with Geisinger on an AI model that can accurately identify undiagnosed structural heart disease (SHD).

What You Should Know:  Tempus, an $8B precision medicine company, announced a collaborative study with Geisinger focusing on artificial intelligence (AI) model that can accurately identify patients … [+2588 chars]

full article...